# Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection

> **NCT06268704** · PHASE4 · RECRUITING · sponsor: **University of New Mexico** · enrollment: 230 (estimated)

## Conditions studied

- Sacroiliac Joint Dysfunction
- Sacro-Iliac Spondylosis

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Methylprednisolone
- **DRUG:** 2% Lidocaine HCl Injection

## Key facts

- **NCT ID:** NCT06268704
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-27
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06268704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06268704, "Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06268704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*